As of January 23, 2025, LianBio (LIAN) has a market cap of $34.472 million USD. According to our data, LianBio is ranked No.8356 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $34.47 M |
20.38%
|
Dec 31, 2024 | $28.64 M |
55.70%
|
Dec 29, 2023 | $18.39 M |
172.56%
|
Dec 30, 2022 | $6.75 M |
-73.38%
|
Dec 31, 2021 | $25.35 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
BeiGene
BGNE
|
$20.21 B |
-0.311 B
|
China
|
Zai Lab
ZLAB
|
$3.03 B |
0.125 B
|
China
|
HUTCHMED
HCM
|
$2.42 B |
-0.000 M
|
Hong Kong
|
I-Mab Biopharma
IMAB
|
$87.21 M |
-0.000 M
|
China
|
Sino Biopharmaceutical
1177.HK
|
$6.75 B |
-0.023 B
|
China
|
Hansoh Pharma
3692.HK
|
$13.23 B |
-0.030 B
|
China
|
Market Cap | = | LIAN Stock Price | * | LIAN Shares Outstanding |
= | $0.24 | * | 0.11 B | |
= | $34.47 M |